
Venus Concept VERO
Quarterly report 2025-Q3
added 05-16-2026
Venus Concept P/E Ratio 2011-2026 | VERO
Annual P/E Ratio Venus Concept
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.0392 | -0.0104 | -0.0171 | -4.02 | -0.852 | -1.53 | -1.04 | -8.56 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.0104 | -8.56 | -2.01 |
P/E Ratio of other stocks in the Medical devices industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Cutera
CUTR
|
-0.813 | - | -10.19 % | $ 1.99 M | ||
|
EDAP TMS S.A.
EDAP
|
-3.16 | - | - | $ 162 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
-50 | - | - | $ 1.77 B | ||
|
Avinger
AVGR
|
-0.142 | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
-47.3 | - | - | $ 3.31 B | ||
|
Eargo
EAR
|
-0.108 | - | - | $ 10.2 M | ||
|
Lianluo Smart Limited
LLIT
|
-45.2 | - | 24.59 % | $ 44.8 M | ||
|
Allied Healthcare Products
AHPI
|
-2.78 | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-2.84 | - | -5.86 % | $ 30.6 M | ||
|
ClearPoint Neuro
CLPT
|
-12.4 | $ 14.0 | 3.02 % | $ 396 M | ||
|
Apollo Endosurgery
APEN
|
-10.1 | - | - | $ 475 M | ||
|
Alphatec Holdings
ATEC
|
-14.4 | $ 8.2 | -0.73 % | $ 1.23 B | ||
|
Aziyo Biologics
AZYO
|
-0.714 | - | 1.37 % | $ 20.5 M | ||
|
BioSig Technologies
BSGM
|
-0.707 | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
-0.00929 | - | -13.19 % | $ 166 K | ||
|
IRIDEX Corporation
IRIX
|
-3.74 | $ 1.12 | - | $ 19 M | ||
|
Conformis
CFMS
|
-0.25 | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
-16.3 | - | 0.15 % | $ 844 M | ||
|
Helius Medical Technologies
HSDT
|
-98.5 | $ 1.49 | 0.34 % | $ 32.9 M | ||
|
CryoLife, Inc.
CRY
|
-54.3 | - | -4.14 % | $ 702 M | ||
|
CHF Solutions, Inc.
CHFS
|
-0.0578 | - | 1.15 % | $ 34.5 M | ||
|
Cytosorbents Corporation
CTSO
|
-4.25 | $ 0.44 | 4.12 % | $ 27.4 M | ||
|
LivaNova PLC
LIVN
|
-15.7 | $ 79.08 | 2.48 % | $ 4.31 B | ||
|
Pulmonx Corporation
LUNG
|
-1.35 | $ 1.53 | - | $ 62.2 M | ||
|
OrthoPediatrics Corp.
KIDS
|
-11 | $ 18.63 | 0.76 % | $ 437 M | ||
|
Delcath Systems
DCTH
|
121 | $ 11.69 | - | $ 419 M | ||
|
Soliton, Inc.
SOLY
|
-15.7 | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
-875 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
-31 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
-10.6 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
-27.2 | - | - | $ 111 M | ||
|
LENSAR
LNSR
|
-2.08 | $ 5.69 | - | $ 68 M | ||
|
Dynatronics Corporation
DYNT
|
-0.179 | - | 14.99 % | $ 929 K | ||
|
Orthofix Medical
OFIX
|
-5.33 | $ 9.94 | 0.71 % | $ 394 M | ||
|
Electromed
ELMD
|
23.2 | $ 37.57 | 3.53 % | $ 318 M | ||
|
MiMedx Group
MDXG
|
16 | $ 3.73 | 0.4 % | $ 551 M | ||
|
Butterfly Network
BFLY
|
-12.3 | $ 5.46 | 6.43 % | $ 1.35 B | ||
|
Intersect ENT, Inc.
XENT
|
-10.2 | - | - | $ 955 M | ||
|
Second Sight Medical Products
EYES
|
9.6 | - | -0.97 % | $ 54.4 M | ||
|
Myomo
MYO
|
-2.17 | $ 1.41 | 6.82 % | $ 59 M | ||
|
GBS
GBS
|
-0.235 | - | -0.57 % | $ 7.12 M | ||
|
Globus Medical
GMED
|
23.2 | $ 81.69 | -1.01 % | $ 11 B | ||
|
Insulet Corporation
PODD
|
73.4 | $ 156.65 | -1.86 % | $ 11 B | ||
|
Profound Medical Corp.
PROF
|
-3.9 | $ 6.8 | -0.29 % | $ 206 M | ||
|
CONMED Corporation
CNMD
|
28 | $ 36.69 | -0.46 % | $ 1.14 B | ||
|
Inspire Medical Systems
INSP
|
12.1 | $ 42.96 | 1.85 % | $ 1.26 B | ||
|
Integer Holdings Corporation
ITGR
|
29 | $ 93.62 | -0.37 % | $ 3.25 B | ||
|
Invacare Corporation
IVC
|
-1.17 | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
45.5 | $ 86.25 | -1.45 % | $ 50.4 B | ||
|
Sintx Technologies
SINT
|
-0.666 | $ 2.13 | 0.71 % | $ 5.91 M |